Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

Gabriele Fabbri, Ilaria Mastrorosa, Alessandra Vergori, Valentina Mazzotta, Carmela Pinnetti, Susanna Grisetti, Mauro Zaccarelli, Adriana Ammassari, Andrea Antinori

ABSTRACT

BACKGROUND: Reactivation of occult or inactive Hepatitis B virus (HBV) infection during immunosuppressant treatments is well known and widely described in literature. The same observation has been made in Hepatitis C (HCV)-infected patients previously exposed to HBV and treated with interferon-free DAA treatments. Because of common transmission routes, persons may have been exposed to HCV, HBV and HIV, but few cases have been reported in this scenario to date. Frequency of HBV reactivation in HIV/HCV co-infected patients previously exposed to HBV and treated with DAA remains unclear. Herein, we report an episode of HBV reactivation in an HIV/HCV co-infected patient prescribed with sofosbuvir/ledipasvir for HCV. CASE PRESENTATION: The patient is a Caucasian 54-years old female, with HIV/HCV co-infection (genotype 4), and a previous exposure to HBV, documented by negativity of HBsAg and positivity of HBsAb and HBcAb. Her medical history included: myocardial infarct, chronic kidney disease stage 3, chronic obstructive pulmonary disease, and mild pulmonary hypertension. HCV had not been treated with interferon (IFN)-based regimens and liver stiffness was 10.5 KPa (Metavir stage F3) at hepatic elastography. Because of CKD, she was prescribed with a nucleoside reverse transcriptase (NRTI)-sparing regimen including darunavir/ritonavir plus etravirine, and thereafter with sofosbuvir/ledipasvir for 12 weeks. Four weeks after DAA termination, the patient was hospitalized with symptoms of acute hepatitis. Blood tests showed HCV RNA <12 IU/ml, but positivity of HBAg, HBeAg, and of anti-core antibodies (IgM and IgG), while anti-HBs and anti-HBe antibodies were negative. HBV DNA was 6.06 Log10 IU/ml. Entecavir was started obtaining resolution of symptoms, normalization of liver enzymes, as well as reduction of HBV DNA and of quantitative HBV surface antigen. CONCLUSIONS: This case-report highlights the risk of HBV reactivation with interferon-free DAA treatment in HIV/HCV co-infected patients previously exposed to HBV and who have contraindications for treatment with nucleoside/nucleotide reverse transcriptase Inhibitors because of comorbid conditions. In the setting of HIV infection, clinicians prescribing DAA should be aware of this risk, and HBV assessment at treatment start as well as virological monitoring during DAA treatment is recommended. Large epidemiological and virological studies are needed to investigate reactivation of occult HBV infection more in depth. More... »

PAGES

182

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12879-017-2287-y

DOI

http://dx.doi.org/10.1186/s12879-017-2287-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084250331

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28249574


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzimidazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coinfection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorenes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B Antibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B Surface Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis B virus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sofosbuvir", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "National Institute of Infectious Diseases \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00152, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fabbri", 
        "givenName": "Gabriele", 
        "id": "sg:person.016712176707.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016712176707.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "National Institute of Infectious Diseases \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00152, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mastrorosa", 
        "givenName": "Ilaria", 
        "id": "sg:person.07623311107.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07623311107.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "National Institute of Infectious Diseases \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00152, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vergori", 
        "givenName": "Alessandra", 
        "id": "sg:person.010145156647.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010145156647.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "National Institute of Infectious Diseases \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00152, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mazzotta", 
        "givenName": "Valentina", 
        "id": "sg:person.010742537247.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010742537247.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "National Institute of Infectious Diseases \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00152, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pinnetti", 
        "givenName": "Carmela", 
        "id": "sg:person.01264755562.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264755562.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "National Institute of Infectious Diseases \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00152, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grisetti", 
        "givenName": "Susanna", 
        "id": "sg:person.0720344124.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720344124.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "National Institute of Infectious Diseases \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00152, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zaccarelli", 
        "givenName": "Mauro", 
        "id": "sg:person.01160510471.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160510471.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "National Institute of Infectious Diseases \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00152, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ammassari", 
        "givenName": "Adriana", 
        "id": "sg:person.01012755035.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012755035.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "National Institute of Infectious Diseases \u201cLazzaro Spallanzani\u201d, Via Portuense 292, 00152, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Antinori", 
        "givenName": "Andrea", 
        "id": "sg:person.0675523721.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675523721.85"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s15010-016-0891-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003809792", 
          "https://doi.org/10.1007/s15010-016-0891-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcv.2016.02.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007800397"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11904-015-0275-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009451272", 
          "https://doi.org/10.1007/s11904-015-0275-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hep.510250338", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015004927"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m204241200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015855135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcv.2014.04.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016771676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12328-016-0657-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017036769", 
          "https://doi.org/10.1007/s12328-016-0657-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12328-016-0657-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017036769", 
          "https://doi.org/10.1007/s12328-016-0657-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-8278(02)00296-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017694870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2007.05.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017842158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcv.2005.10.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020850943"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dkw203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021727347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jiac.2016.01.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022591863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jvi.00541-07", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026311374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/00365520903329585", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035197768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hep.22794", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035529056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13256-015-0630-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036889926", 
          "https://doi.org/10.1186/s13256-015-0630-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/cid/civ474", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045015101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/hepr.12578", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046924658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/cid/ciw507", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059468007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3851/imp3066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071480112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4254/wjh.v6.i6.384", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072403295"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4254/wjh.v7.i3.498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072403546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079363784", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "BACKGROUND: Reactivation of occult or inactive Hepatitis B virus (HBV) infection during immunosuppressant treatments is well known and widely described in literature. The same observation has been made in Hepatitis C (HCV)-infected patients previously exposed to HBV and treated with interferon-free DAA treatments. Because of common transmission routes, persons may have been exposed to HCV, HBV and HIV, but few cases have been reported in this scenario to date. Frequency of HBV reactivation in HIV/HCV co-infected patients previously exposed to HBV and treated with DAA remains unclear. Herein, we report an episode of HBV reactivation in an HIV/HCV co-infected patient prescribed with sofosbuvir/ledipasvir for HCV.\nCASE PRESENTATION: The patient is a Caucasian 54-years old female, with HIV/HCV co-infection (genotype 4), and a previous exposure to HBV, documented by negativity of HBsAg and positivity of HBsAb and HBcAb. Her medical history included: myocardial infarct, chronic kidney disease stage 3, chronic obstructive pulmonary disease, and mild pulmonary hypertension. HCV had not been treated with interferon (IFN)-based regimens and liver stiffness was 10.5\u00a0KPa (Metavir stage F3) at hepatic elastography. Because of CKD, she was prescribed with a nucleoside reverse transcriptase (NRTI)-sparing regimen including darunavir/ritonavir plus etravirine, and thereafter with sofosbuvir/ledipasvir for 12\u00a0weeks. Four weeks after DAA termination, the patient was hospitalized with symptoms of acute hepatitis. Blood tests showed HCV RNA <12\u00a0IU/ml, but positivity of HBAg, HBeAg, and of anti-core antibodies (IgM and IgG), while anti-HBs and anti-HBe antibodies were negative. HBV DNA was 6.06 Log10 IU/ml. Entecavir was started obtaining resolution of symptoms, normalization of liver enzymes, as well as reduction of HBV DNA and of quantitative HBV surface antigen.\nCONCLUSIONS: This case-report highlights the risk of HBV reactivation with interferon-free DAA treatment in HIV/HCV co-infected patients previously exposed to HBV and who have contraindications for treatment with nucleoside/nucleotide reverse transcriptase Inhibitors because of comorbid conditions. In the setting of HIV infection, clinicians prescribing DAA should be aware of this risk, and HBV assessment at treatment start as well as virological monitoring during DAA treatment is recommended. Large epidemiological and virological studies are needed to investigate reactivation of occult HBV infection more in depth.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12879-017-2287-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024946", 
        "issn": [
          "1471-2334"
        ], 
        "name": "BMC Infectious Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature", 
    "pagination": "182", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "cd77c67183cd7d01eb9be000088856f4ddde044ee365af24118ee29285544759"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28249574"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968551"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12879-017-2287-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084250331"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12879-017-2287-y", 
      "https://app.dimensions.ai/details/publication/pub.1084250331"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113640_00000004.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12879-017-2287-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12879-017-2287-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12879-017-2287-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12879-017-2287-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12879-017-2287-y'


 

This table displays all metadata directly associated to this object as RDF triples.

267 TRIPLES      21 PREDICATES      66 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12879-017-2287-y schema:about N064a34df60e74c51999d9699a1faa387
2 N128f5e3dbd2c43ebaf61762cd2485951
3 N1d096a8d94ce48328c8d7fc8d5834f23
4 N1fb540fe615047e3b76ac3b75705d1d7
5 N3e60f45be4884e788bf79e582b3b9b78
6 N3ffe624634394f99ae44edb6ab0ee62a
7 N4349f0c9bb3e484eab1158eac00d7d5d
8 N471ae4cc1c34431c990aafd7cc96538f
9 N544242215c604a3c98a3067330720a84
10 N89cc54f7d76549a98bb3bfa7367e6732
11 N9798b0604d7d45fea5f4fc61298feac9
12 Na53c83a19777419fb42b2f52e37f9559
13 Nb7f468907347437794cba39f76e40308
14 Nc622cd5d380b426eb5a5b2853d1c1134
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author Nf9ae3096fc9142eaa5f0101558ed08e4
18 schema:citation sg:pub.10.1007/s11904-015-0275-7
19 sg:pub.10.1007/s12328-016-0657-4
20 sg:pub.10.1007/s15010-016-0891-1
21 sg:pub.10.1186/s13256-015-0630-8
22 https://app.dimensions.ai/details/publication/pub.1079363784
23 https://doi.org/10.1002/hep.22794
24 https://doi.org/10.1002/hep.510250338
25 https://doi.org/10.1016/j.bbmt.2007.05.009
26 https://doi.org/10.1016/j.jcv.2005.10.006
27 https://doi.org/10.1016/j.jcv.2014.04.021
28 https://doi.org/10.1016/j.jcv.2016.02.026
29 https://doi.org/10.1016/j.jiac.2016.01.004
30 https://doi.org/10.1016/s0168-8278(02)00296-9
31 https://doi.org/10.1074/jbc.m204241200
32 https://doi.org/10.1093/cid/civ474
33 https://doi.org/10.1093/cid/ciw507
34 https://doi.org/10.1093/jac/dkw203
35 https://doi.org/10.1111/hepr.12578
36 https://doi.org/10.1128/jvi.00541-07
37 https://doi.org/10.3109/00365520903329585
38 https://doi.org/10.3851/imp3066
39 https://doi.org/10.4254/wjh.v6.i6.384
40 https://doi.org/10.4254/wjh.v7.i3.498
41 schema:datePublished 2017-12
42 schema:datePublishedReg 2017-12-01
43 schema:description BACKGROUND: Reactivation of occult or inactive Hepatitis B virus (HBV) infection during immunosuppressant treatments is well known and widely described in literature. The same observation has been made in Hepatitis C (HCV)-infected patients previously exposed to HBV and treated with interferon-free DAA treatments. Because of common transmission routes, persons may have been exposed to HCV, HBV and HIV, but few cases have been reported in this scenario to date. Frequency of HBV reactivation in HIV/HCV co-infected patients previously exposed to HBV and treated with DAA remains unclear. Herein, we report an episode of HBV reactivation in an HIV/HCV co-infected patient prescribed with sofosbuvir/ledipasvir for HCV. CASE PRESENTATION: The patient is a Caucasian 54-years old female, with HIV/HCV co-infection (genotype 4), and a previous exposure to HBV, documented by negativity of HBsAg and positivity of HBsAb and HBcAb. Her medical history included: myocardial infarct, chronic kidney disease stage 3, chronic obstructive pulmonary disease, and mild pulmonary hypertension. HCV had not been treated with interferon (IFN)-based regimens and liver stiffness was 10.5 KPa (Metavir stage F3) at hepatic elastography. Because of CKD, she was prescribed with a nucleoside reverse transcriptase (NRTI)-sparing regimen including darunavir/ritonavir plus etravirine, and thereafter with sofosbuvir/ledipasvir for 12 weeks. Four weeks after DAA termination, the patient was hospitalized with symptoms of acute hepatitis. Blood tests showed HCV RNA <12 IU/ml, but positivity of HBAg, HBeAg, and of anti-core antibodies (IgM and IgG), while anti-HBs and anti-HBe antibodies were negative. HBV DNA was 6.06 Log10 IU/ml. Entecavir was started obtaining resolution of symptoms, normalization of liver enzymes, as well as reduction of HBV DNA and of quantitative HBV surface antigen. CONCLUSIONS: This case-report highlights the risk of HBV reactivation with interferon-free DAA treatment in HIV/HCV co-infected patients previously exposed to HBV and who have contraindications for treatment with nucleoside/nucleotide reverse transcriptase Inhibitors because of comorbid conditions. In the setting of HIV infection, clinicians prescribing DAA should be aware of this risk, and HBV assessment at treatment start as well as virological monitoring during DAA treatment is recommended. Large epidemiological and virological studies are needed to investigate reactivation of occult HBV infection more in depth.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree true
47 schema:isPartOf Nd9fd9e1a07b7433daf495ebe07e9ed3e
48 Ne5687e736f264ae99cae0ce4321f382f
49 sg:journal.1024946
50 schema:name Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature
51 schema:pagination 182
52 schema:productId N03943b920731477289caf94fcdfa38f0
53 N4650f99821004e4883297a9f9183a857
54 N5b5374b5653b4f519bdf329e1402864d
55 Na5d3093d17b54aa5961d92bac85d83ef
56 Nc7411dc0d8ca45e7a391b87621df61e0
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084250331
58 https://doi.org/10.1186/s12879-017-2287-y
59 schema:sdDatePublished 2019-04-11T10:28
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher N65ec3fabb4704ad39366d4e3accb105b
62 schema:url https://link.springer.com/10.1186%2Fs12879-017-2287-y
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N00b9a99032064b2998ee646f64be3920 schema:name National Institute of Infectious Diseases “Lazzaro Spallanzani”, Via Portuense 292, 00152, Rome, Italy
67 rdf:type schema:Organization
68 N03943b920731477289caf94fcdfa38f0 schema:name doi
69 schema:value 10.1186/s12879-017-2287-y
70 rdf:type schema:PropertyValue
71 N064a34df60e74c51999d9699a1faa387 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name HIV Infections
73 rdf:type schema:DefinedTerm
74 N0720ef73eb3f46ababc296735f68325a schema:name National Institute of Infectious Diseases “Lazzaro Spallanzani”, Via Portuense 292, 00152, Rome, Italy
75 rdf:type schema:Organization
76 N128f5e3dbd2c43ebaf61762cd2485951 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Female
78 rdf:type schema:DefinedTerm
79 N1d096a8d94ce48328c8d7fc8d5834f23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Hepatitis B Antibodies
81 rdf:type schema:DefinedTerm
82 N1fb540fe615047e3b76ac3b75705d1d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Hepatitis C
84 rdf:type schema:DefinedTerm
85 N22a2f9f4f7c14786b6f42ada7238ebc9 schema:name National Institute of Infectious Diseases “Lazzaro Spallanzani”, Via Portuense 292, 00152, Rome, Italy
86 rdf:type schema:Organization
87 N35e285181d1c498b950c08dc77cd2869 rdf:first sg:person.0675523721.85
88 rdf:rest rdf:nil
89 N371bf97788734c689b598c1c2eb63908 rdf:first sg:person.010742537247.51
90 rdf:rest Nbe2386f546d24e9db9f37b1585f51569
91 N3e60f45be4884e788bf79e582b3b9b78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Sofosbuvir
93 rdf:type schema:DefinedTerm
94 N3f865561462346f0b9562dc709837409 rdf:first sg:person.0720344124.37
95 rdf:rest Nba055a156e3c44448fd87b4bf66fead0
96 N3ffe624634394f99ae44edb6ab0ee62a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Humans
98 rdf:type schema:DefinedTerm
99 N4349f0c9bb3e484eab1158eac00d7d5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Benzimidazoles
101 rdf:type schema:DefinedTerm
102 N4650f99821004e4883297a9f9183a857 schema:name dimensions_id
103 schema:value pub.1084250331
104 rdf:type schema:PropertyValue
105 N471ae4cc1c34431c990aafd7cc96538f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Hepatitis B virus
107 rdf:type schema:DefinedTerm
108 N517b0f28f4db46718be4e19b654ae8fa rdf:first sg:person.07623311107.59
109 rdf:rest Nb22f971ed3c646e9b20ad7efba5b1e56
110 N544242215c604a3c98a3067330720a84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Fluorenes
112 rdf:type schema:DefinedTerm
113 N5850a964524e4defb0e7e1bef30afc68 schema:name National Institute of Infectious Diseases “Lazzaro Spallanzani”, Via Portuense 292, 00152, Rome, Italy
114 rdf:type schema:Organization
115 N5b5374b5653b4f519bdf329e1402864d schema:name pubmed_id
116 schema:value 28249574
117 rdf:type schema:PropertyValue
118 N65ec3fabb4704ad39366d4e3accb105b schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 N756acfcbda5147e089a5cc00186cc9de schema:name National Institute of Infectious Diseases “Lazzaro Spallanzani”, Via Portuense 292, 00152, Rome, Italy
121 rdf:type schema:Organization
122 N7e76e0be4f514b6f93dfded9f187ad2b schema:name National Institute of Infectious Diseases “Lazzaro Spallanzani”, Via Portuense 292, 00152, Rome, Italy
123 rdf:type schema:Organization
124 N89cc54f7d76549a98bb3bfa7367e6732 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Hepatitis B
126 rdf:type schema:DefinedTerm
127 N9798b0604d7d45fea5f4fc61298feac9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Middle Aged
129 rdf:type schema:DefinedTerm
130 N9d05a84c16724e429b3a7c7d644e852e schema:name National Institute of Infectious Diseases “Lazzaro Spallanzani”, Via Portuense 292, 00152, Rome, Italy
131 rdf:type schema:Organization
132 Na53c83a19777419fb42b2f52e37f9559 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Hepatitis B Surface Antigens
134 rdf:type schema:DefinedTerm
135 Na5d3093d17b54aa5961d92bac85d83ef schema:name nlm_unique_id
136 schema:value 100968551
137 rdf:type schema:PropertyValue
138 Naff202672d45422b8053f052221b936e rdf:first sg:person.01012755035.52
139 rdf:rest N35e285181d1c498b950c08dc77cd2869
140 Nb22f971ed3c646e9b20ad7efba5b1e56 rdf:first sg:person.010145156647.34
141 rdf:rest N371bf97788734c689b598c1c2eb63908
142 Nb7f468907347437794cba39f76e40308 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Antiviral Agents
144 rdf:type schema:DefinedTerm
145 Nba055a156e3c44448fd87b4bf66fead0 rdf:first sg:person.01160510471.36
146 rdf:rest Naff202672d45422b8053f052221b936e
147 Nbe2386f546d24e9db9f37b1585f51569 rdf:first sg:person.01264755562.24
148 rdf:rest N3f865561462346f0b9562dc709837409
149 Nc622cd5d380b426eb5a5b2853d1c1134 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Coinfection
151 rdf:type schema:DefinedTerm
152 Nc7411dc0d8ca45e7a391b87621df61e0 schema:name readcube_id
153 schema:value cd77c67183cd7d01eb9be000088856f4ddde044ee365af24118ee29285544759
154 rdf:type schema:PropertyValue
155 Nd49137ffcdf94e7c80cfc5bbace81a5e schema:name National Institute of Infectious Diseases “Lazzaro Spallanzani”, Via Portuense 292, 00152, Rome, Italy
156 rdf:type schema:Organization
157 Nd9fd9e1a07b7433daf495ebe07e9ed3e schema:volumeNumber 17
158 rdf:type schema:PublicationVolume
159 Ne5687e736f264ae99cae0ce4321f382f schema:issueNumber 1
160 rdf:type schema:PublicationIssue
161 Neaef156b15da4567be6f144adbc83e51 schema:name National Institute of Infectious Diseases “Lazzaro Spallanzani”, Via Portuense 292, 00152, Rome, Italy
162 rdf:type schema:Organization
163 Nf9ae3096fc9142eaa5f0101558ed08e4 rdf:first sg:person.016712176707.98
164 rdf:rest N517b0f28f4db46718be4e19b654ae8fa
165 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
166 schema:name Medical and Health Sciences
167 rdf:type schema:DefinedTerm
168 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
169 schema:name Clinical Sciences
170 rdf:type schema:DefinedTerm
171 sg:journal.1024946 schema:issn 1471-2334
172 schema:name BMC Infectious Diseases
173 rdf:type schema:Periodical
174 sg:person.01012755035.52 schema:affiliation N0720ef73eb3f46ababc296735f68325a
175 schema:familyName Ammassari
176 schema:givenName Adriana
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012755035.52
178 rdf:type schema:Person
179 sg:person.010145156647.34 schema:affiliation Neaef156b15da4567be6f144adbc83e51
180 schema:familyName Vergori
181 schema:givenName Alessandra
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010145156647.34
183 rdf:type schema:Person
184 sg:person.010742537247.51 schema:affiliation Nd49137ffcdf94e7c80cfc5bbace81a5e
185 schema:familyName Mazzotta
186 schema:givenName Valentina
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010742537247.51
188 rdf:type schema:Person
189 sg:person.01160510471.36 schema:affiliation N9d05a84c16724e429b3a7c7d644e852e
190 schema:familyName Zaccarelli
191 schema:givenName Mauro
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160510471.36
193 rdf:type schema:Person
194 sg:person.01264755562.24 schema:affiliation N5850a964524e4defb0e7e1bef30afc68
195 schema:familyName Pinnetti
196 schema:givenName Carmela
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264755562.24
198 rdf:type schema:Person
199 sg:person.016712176707.98 schema:affiliation N7e76e0be4f514b6f93dfded9f187ad2b
200 schema:familyName Fabbri
201 schema:givenName Gabriele
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016712176707.98
203 rdf:type schema:Person
204 sg:person.0675523721.85 schema:affiliation N22a2f9f4f7c14786b6f42ada7238ebc9
205 schema:familyName Antinori
206 schema:givenName Andrea
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675523721.85
208 rdf:type schema:Person
209 sg:person.0720344124.37 schema:affiliation N756acfcbda5147e089a5cc00186cc9de
210 schema:familyName Grisetti
211 schema:givenName Susanna
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720344124.37
213 rdf:type schema:Person
214 sg:person.07623311107.59 schema:affiliation N00b9a99032064b2998ee646f64be3920
215 schema:familyName Mastrorosa
216 schema:givenName Ilaria
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07623311107.59
218 rdf:type schema:Person
219 sg:pub.10.1007/s11904-015-0275-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009451272
220 https://doi.org/10.1007/s11904-015-0275-7
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/s12328-016-0657-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017036769
223 https://doi.org/10.1007/s12328-016-0657-4
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/s15010-016-0891-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003809792
226 https://doi.org/10.1007/s15010-016-0891-1
227 rdf:type schema:CreativeWork
228 sg:pub.10.1186/s13256-015-0630-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036889926
229 https://doi.org/10.1186/s13256-015-0630-8
230 rdf:type schema:CreativeWork
231 https://app.dimensions.ai/details/publication/pub.1079363784 schema:CreativeWork
232 https://doi.org/10.1002/hep.22794 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035529056
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1002/hep.510250338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015004927
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/j.bbmt.2007.05.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017842158
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/j.jcv.2005.10.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020850943
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/j.jcv.2014.04.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016771676
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/j.jcv.2016.02.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007800397
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/j.jiac.2016.01.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022591863
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/s0168-8278(02)00296-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017694870
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1074/jbc.m204241200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015855135
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1093/cid/civ474 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045015101
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1093/cid/ciw507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059468007
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1093/jac/dkw203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021727347
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1111/hepr.12578 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046924658
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1128/jvi.00541-07 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026311374
259 rdf:type schema:CreativeWork
260 https://doi.org/10.3109/00365520903329585 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035197768
261 rdf:type schema:CreativeWork
262 https://doi.org/10.3851/imp3066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071480112
263 rdf:type schema:CreativeWork
264 https://doi.org/10.4254/wjh.v6.i6.384 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072403295
265 rdf:type schema:CreativeWork
266 https://doi.org/10.4254/wjh.v7.i3.498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072403546
267 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...